We are investigating Vical, Inc. (VICL) related to its merger with Brickell Biotech, Inc. Under the terms of the proposed transaction, Vical shareholders will only own 40% of the combined company.
We are investigating Vical, Inc. (VICL) related to its merger with Brickell Biotech, Inc. Under the terms of the proposed transaction, Vical shareholders will only own 40% of the combined company.